POH01 Innovations in Immunodermatology: Advances in Autoimmune Bullous and Connective Tissue Diseases
DESCRIPTION
Immunodermatology continues to advance our understanding and management of complex autoimmune bullous disorders and connective tissue diseases. This session will highlight cutting-edge diagnostic tools, immune-based biomarkers, and therapeutic breakthroughs that are reshaping clinical practice. Attendees will participate in dynamic discussions on the future of immune-mediated skin disease management, with a focus on practical strategies to recognize, monitor, and treat challenging cases. Faculty will share emerging paradigms that bridge research and practice, offering attendees a unique opportunity to engage with leading specialists driving innovation in the field.
LEARNING OBJECTIVES
Review current and emerging advances in autoimmune bullous disorders and connective tissue diseases.
Apply innovative diagnostic and therapeutic strategies to improve patient outcomes.
Discuss cutting-edge tools and the future of immune-mediated skin disease management.
DIRECTOR
Alina G. Bridges, DO, FAAD
Donald and Barbara Zucker School of Medicine at Hofstra/Northwell
SPEAKER
Julia S. Lehman, MD, FAAD
Mayo Clinic
DISCLOSURES
Alina G. Bridges, DO, FAAD
No financial relationships exist with ineligible companies.
Julia S. Lehman, MD, FAAD
No financial relationships exist with ineligible companies.